Pharmacoeconomics requirements in Asia (PharmaFocus Asia, April 2006)
Peter Davey, Principal, HEOR in Asia-Pacific and Japan, reviews pharmacoeconomics requirements in Asia in the wake of new guidelines being developed for Korea.
Peter considers their potential implications and the lessons that may be drawn from the experience of the UK and Australia. From the April issue of PharmaFocus Asia, download it here.